Skip to main content

Clinical trial BE-QUALMS

A Multicenter observational Belgian study assessing the impact of newly started treatment on the QOL in patients suffering from myelodysplastic syndromes

Organ Blood
Trial status Trial closed
Trial type
Prospective observational study
Phase Trial phase 4
Academic trial Non
BECT Identifier B300201938708
Inclusion criteria - Newly diagnosed patients with myelodysplastic syndromes defined by WHO 2016 criteria that are about to start treatment.- Patients with a known diagnosis of MDS, irrespective of IPSS and irrespective of time of diagnosis that are about to start a new th
Last update